Very good reward to risk probability

The Pharmaceutical industry develops and commercialises more and more Biopharmaceuticals. The market for these drugs ($60 billion in 2005) already represents more than 10% of the total drug market, outperfoming conventional small organic drugs by annual growth rates more than 15%. Due to its nature most of these large molecule drugs can only be injected. Unfortunately injections can cause fear with patients, lower compliance and increase risk of infection.

In reaction to this strong market demand Pantec Biosolutions offers a convenient painless drug delivery system for biopharmaceuticals which satisfies the needs of all major industry stakeholders (patients, physicians, pharmaceutical companies and healthcare insurances).

You will get a very good reward to risk probability because

• You will participate in the exciting drug delivery industry, a fast growing industry at the interface between Medtech and Pharma.
• You will be part of a great team that has proven entrepreneurial commercial success records.
• Quicker “time to market” and lower “risk to market” compared to Biotech ventures.
• Human cutaneous tolerability study completed successfully.
• First co-operation agreement with Pharma partner already in place.
• Second financing round has started successfully with CHF 2.0m.